Intramedullary nailing versus plate compound osteosynthesis in subtrochanteric and diaphyseal pathologic femoral fractures: a retrospective cohort study.


Journal

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
ISSN: 1432-1068
Titre abrégé: Eur J Orthop Surg Traumatol
Pays: France
ID NLM: 9518037

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 03 05 2023
accepted: 17 05 2023
medline: 16 11 2023
pubmed: 29 5 2023
entrez: 29 5 2023
Statut: ppublish

Résumé

Pathologic fractures of the extremities due to carcinoma metastases require individual and patient prognosis-related stabilization procedures. Quick remobilization of the patient to restore the quality of life is of high importance, especially in the case of subtrochanteric and diaphyseal femoral fractures. In our retrospective cohort study, we evaluated intraoperative blood loss, length of operation, complication rate, and regain of lower extremity function in plate compound osteosynthesis (PCO) versus intramedullary nailing (IM) for subtrochanteric and diaphyseal pathologic fractures of the femur. Between January 2010 and July 2021, we retrospectively reviewed 49 patients who were treated at our institution for pathologic fractures of the subtrochanteric and diaphyseal femurs for group differences in terms of blood loss, length of operation, implant survival, and Musculoskeletal Tumor Society (MSTS) score. We included 49 stabilization procedures of the lower extremity due to pathologic fractures of the proximal or diaphyseal femur, with a mean follow-up of 17.7 months. IM (n = 29) had a significantly shorter operation time than PCO (n = 20) (112.4 ± 9.4 and 163.3 ± 15.96 min, respectively). We did not detect any significant differences in terms of blood loss, complication rate, implant survival, or MSTS score. Based on our data, pathologic subtrochanteric and diaphyseal fractures of the femur can be stabilized with IM, which has a shorter operation time than PCO, but the complication rate, implant survival, and blood loss remain unaffected.

Identifiants

pubmed: 37246990
doi: 10.1007/s00590-023-03599-7
pii: 10.1007/s00590-023-03599-7
pmc: PMC10651703
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3597-3601

Informations de copyright

© 2023. The Author(s).

Références

Chin J Cancer Res. 2016 Apr;28(2):209-14
pubmed: 27199518
Injury. 2014 Feb;45(2):412-7
pubmed: 24119652
Clin Orthop Relat Res. 2018 Dec;476(12):2392-2401
pubmed: 30299285
J Am Acad Orthop Surg. 2016 Jul;24(7):483-94
pubmed: 27227983
Clin Orthop Relat Res. 2013 Jun;471(6):2000-6
pubmed: 23247815
Orthopade. 2009 Apr;38(4):324, 326-8, 330-4
pubmed: 19296079
Orthop Traumatol Surg Res. 2020 Oct;106(6):1013-1023
pubmed: 32778439
Clin Orthop Relat Res. 2018 Sep;476(9):1823-1833
pubmed: 30566108
Arch Orthop Trauma Surg. 2016 Apr;136(4):539-51
pubmed: 26762137
Malays Orthop J. 2017 Mar;11(1):28-34
pubmed: 28435571
Clin Orthop Relat Res. 1993 Jan;(286):241-6
pubmed: 8425352
J Bone Joint Surg Br. 2005 Dec;87(12):1653-7
pubmed: 16326880
Z Orthop Unfall. 2019 Aug;157(4):401-410
pubmed: 30616258
Clin Orthop Relat Res. 2015 Apr;473(4):1499-502
pubmed: 25424158

Auteurs

Sebastian Koob (S)

Department of Orthopaedics and Trauma Surgery, University of Bonn, Venusberg Campus 1, 53127, Bonn, Germany. Sebastian.Koob@ukbonn.de.

Milena Maria Plöger (MM)

Department of Orthopaedics and Trauma Surgery, University of Bonn, Venusberg Campus 1, 53127, Bonn, Germany.

Johanna Sophie Schmolling (JS)

Department of Orthopaedics and Trauma Surgery, University of Bonn, Venusberg Campus 1, 53127, Bonn, Germany.

Ramona Pia Lehmann (RP)

Department of Orthopaedics and Trauma Surgery, University of Bonn, Venusberg Campus 1, 53127, Bonn, Germany.

Dana Alex (D)

Department of Orthopaedics and Trauma Surgery, University of Bonn, Venusberg Campus 1, 53127, Bonn, Germany.

Hendrik Kohlhof (H)

Department of Emergency, Hand and Orthopaedic Surgery, St. Antonius Hospital, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH